LSZ-102
LSZ-102 Uses, Dosage, Side Effects, Food Interaction and all others data.
LSZ-102 is under investigation in clinical trial NCT02734615 (Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers).
Trade Name | LSZ-102 |
Generic | LSZ-102 |
Type | |
Formula | C25H17F3O4S |
Weight | Average: 470.46 Monoisotopic: 470.07996469 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here LSZ-102